Sep 20, 2021 / 12:30PM GMT
Operator
Good day, and thank you for standing by. Welcome to the Regeneron Oncology Investor Event, ESMO 2021. (Operator Instructions) Please be advised today's conference may be recorded. (Operator Instructions) I'd now like to hand the conference over to Justin Holko, Vice President, Investor Relations.
Justin Holko - Regeneron Pharmaceuticals, Inc. - VP of IR
Thank you, Liz, and welcome to everybody to join this call this morning. Joining me on the call today are Dr. George Yancopoulos, Co-Founder, President and Chief Scientific Officer; and Dr. Israel Lowy, Senior Vice President of Transitional Sciences and Oncology. After our prepared remarks, we'll open the call for Q&A.
Before handing the call over to George, however, I would like to remind you that remarks made on today's call include forward-looking statements about Regeneron, including those related to Regeneron's business and research and development programs, anticipated milestones regulatory matters.
Each forward-looking statement is subject to risks and uncertainties that could cause
Regeneron Pharmaceuticals Inc Oncology Investor Event at ESMO Transcript
Sep 20, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers